Profile
Satori Capital is a private equity firm based in Dallas, Texas, founded in 2008. The firm is known for its commitment to conscious capitalism and has a team of around 35 professionals, including 12 partners. Satori Capital differentiates itself by focusing on long-term partnerships with leadership teams that align with its values, aiming to create value for all stakeholders.
The firm primarily invests in sectors such as power, commercial and industrial services, innovative product and engineering-driven manufacturing, consumer brands, neurotechnology, therapeutics, energy, and mental health. Satori Capital typically targets companies with $5 million to $25 million in EBITDA and operates across the United States. The firm manages several funds, including Satori Capital Fund III with $102 million AUM and Satori Environmental Partners, LP with $19 million AUM.
Notable investments by Satori Capital include Gilgamesh Pharma - drug discovery, QPR Software - software development, Constellation Systems - software development applications, COMFRT - clothing, and NextSense - electronics. The firm has a diverse portfolio and continues to seek new investment opportunities.
Industry
Satori Capital Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Satori Capital Fund III
|
Private Equity (PE)
|
Financial Services
Fintech
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
|
Series B
|
North America
|
$5-10 m
|
$102 M
|
November 2020
|
|
Satori Environmental Partners, LP
|
Private Equity (PE)
|
Financial Services
Fintech
Food and Beverage
Foodtech
Healthcare Services
SaaS
Security
Software
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$19 M
|
April 2023
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.